FRANKFURT: A booster shot of the anti-Covid-19 vaccine developed by Pfizer-BioNTech is 95.6 per cent effective against symptomatic infection, according to trial data published by the makers on Thursday.
© New Straits Times Press (M) Bhd

FRANKFURT: A booster shot of the anti-Covid-19 vaccine developed by Pfizer-BioNTech is 95.6 per cent effective against symptomatic infection, according to trial data published by the makers on Thursday.
© New Straits Times Press (M) Bhd